NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

Utilising Machine Learning on clinical datasets could help to crack the enigma of feline infectious peritonitis diagnosis ...

COVID-19 vaccination averted more than 5,000 US in-hospital deaths, 13,000 intensive care unit (ICU) admissions, and 68,000 ...

President Donald Trump's nominees to run the National Institutes of Health and the Food and Drug Administration are part of a group of scientists censored during the COVID-19 pandemic who are ...

With the rise of omicron came the fall of long-lasting protection from reinfection with the pandemic coronavirus SARS-CoV-2, ...

In a breakthrough for influenza research, scientists have discovered immune cells that can recognize influenza (flu) viruses ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it infects cells. Currently, no approved treatments exist. To address this critical ...

Observational studies are critical tools in clinical research and public health response, but challenges arise in ensuring ...

Influenza A virus particles strategically adapt their shape-to become either spheres or larger filaments-to favor their ability to infect cells depending on environmental conditions, according to a ...

Doctors have found that Covid-19's inflammation can cause long-term cardiovascular issues, such as accelerated plaque buildup ...

A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...